VOYA Investment Management
BIO icon

VOYA Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

VOYA Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$376K Sell
1,349
-20
-1% -$5.76K ﹤0.01% 1853
2025
Q4 		$415K Sell
1,369
-184
-12% -$57.4K ﹤0.01% 1835
2025
Q3 		$435K Sell
1,553
-613
-28% -$167K ﹤0.01% 1822
2025
Q2 		$523K Sell
2,166
-295
-12% -$69.7K ﹤0.01% 1877
2025
Q1 		$599K Buy
2,461
+164
+7% +$49.3K ﹤0.01% 1786
2024
Q4 		$755K Sell
2,297
-215
-9% -$73K ﹤0.01% 1740
2024
Q3 		$840K Sell
2,512
-4,336
-63% -$1.38M ﹤0.01% 1733
2024
Q2 		$1.87M Sell
6,848
-1,055
-13% -$307K ﹤0.01% 1335
2024
Q1 		$2.73M Sell
7,903
-236
-3% -$77.6K ﹤0.01% 1225
2023
Q4 		$2.63M Sell
8,139
-1,835
-18% -$575K ﹤0.01% 1268
2023
Q3 		$3.58M Sell
9,974
-267
-3% -$103K ﹤0.01% 1104
2023
Q2 		$3.88M Buy
10,241
+2,573
+34% +$1.05M ﹤0.01% 1096
2023
Q1 		$3.67M Sell
7,668
-2
-0% -$936 ﹤0.01% 1113
2022
Q4 		$3.23M Sell
7,670
-215
-3% -$86.8K ﹤0.01% 1147
2022
Q3 		$3.29M Sell
7,885
-85
-1% -$42.4K ﹤0.01% 1128
2022
Q2 		$3.94M Sell
7,970
-449
-5% -$234K 0.01% 830
2022
Q1 		$4.74M Sell
8,419
-124
-1% -$74.7K 0.01% 851
2021
Q4 		$6.46M Sell
8,543
-374
-4% -$280K 0.01% 755
2021
Q3 		$6.65M Sell
8,917
-158
-2% -$118K 0.01% 746
2021
Q2 		$5.85M Sell
9,075
-2,677
-23% -$1.63M 0.01% 809
2021
Q1 		$6.71M Sell
11,752
-4,836
-29% -$2.86M 0.01% 736
2020
Q4 		$9.67M Sell
16,588
-9,067
-35% -$5.16M 0.02% 582
2020
Q3 		$13.2M Sell
25,655
-1,161
-4% -$588K 0.03% 441
2020
Q2 		$12.1M Buy
26,816
+11,328
+73% +$5M 0.03% 464
2020
Q1 		$5.43M Buy
15,488
+753
+5% +$277K 0.01% 681
2019
Q4 		$5.45M Buy
14,735
+4,793
+48% +$1.69M 0.01% 779
2019
Q3 		$3.31M Buy
9,942
+1,381
+16% +$451K 0.01% 897
2019
Q2 		$2.68M Buy
8,561
+4,391
+105% +$1.31M 0.01% 965
2019
Q1 		$1.27M Sell
4,170
-270
-6% -$72.9K ﹤0.01% 1245
2018
Q4 		$1.03M Buy
4,440
+96
+2% +$25.8K ﹤0.01% 1301
2018
Q3 		$1.36M Sell
4,344
-110
-2% -$34.1K ﹤0.01% 1242
2018
Q2 		$1.28M Sell
4,454
-1,087
-20% -$300K ﹤0.01% 1247
2018
Q1 		$1.39M Sell
5,541
-111
-2% -$28.3K ﹤0.01% 1225
2017
Q4 		$1.35M Sell
5,652
-221
-4% -$53.6K ﹤0.01% 1248
2017
Q3 		$1.3M Hold
5,873
– – ﹤0.01% 1241
2017
Q2 		$1.33M Sell
5,873
-380
-6% -$82.8K ﹤0.01% 1230
2017
Q1 		$1.25M Sell
6,253
-286
-4% -$55.1K ﹤0.01% 1217
2016
Q4 		$1.19M Sell
6,539
-554
-8% -$94.4K ﹤0.01% 1233
2016
Q3 		$1.16K Buy
7,093
+289
+4% +$43.9K ﹤0.01% 1234
2016
Q2 		$973K Sell
6,804
-52,580
-89% -$7.5M ﹤0.01% 1281
2016
Q1 		$8.12M Sell
59,384
-7,106
-11% -$933K 0.02% 603
2015
Q4 		$9.22M Sell
66,490
-8,612
-11% -$1.19M 0.02% 584
2015
Q3 		$10.1M Sell
75,102
-29,343
-28% -$4.22M 0.03% 561
2015
Q2 		$15.7M Buy
104,445
+8,167
+8% +$1.17M 0.04% 424
2015
Q1 		$13M Sell
96,278
-2,706
-3% -$335K 0.03% 496
2014
Q4 		$11.9M Sell
98,984
-7,977
-7% -$918K 0.03% 535
2014
Q3 		$12.1M Sell
106,961
-156
-0.1% -$18.5K 0.03% 519
2014
Q2 		$12.8M Sell
107,117
-11,076
-9% -$1.35M 0.03% 510
2014
Q1 		$15.1M Buy
118,193
+8,088
+7% +$1.04M 0.04% 451
2013
Q4 		$13.6M Buy
110,105
+12,642
+13% +$1.54M 0.03% 469
2013
Q3 		$11.5M Buy
97,463
+3,505
+4% +$413K 0.03% 515
2013
Q2 		$10.5M Buy
+93,958
New +$11M 0.03% 525

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VOYA Investment Management's BIO Position: Q1 2026 in Review

VOYA Investment Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 1.5% in Q1 2026, selling an estimated $5.76K and leaving 1,349 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1853.

VOYA Investment Management first reported a position in BIO in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.7M in Q2 2015. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • VOYA Investment Management held 1,349 shares of Bio-Rad Laboratories Class A worth $376K as of Q1 2026.
  • VOYA Investment Management sold 20 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $5.76K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1853 holding.
  • VOYA Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Bio-Rad Laboratories Class A position peaked at $15.7M in Q2 2015.
  • 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.